Trident Texofab promoter trust buys 0.26% stake in open market
Hardik Desai Family Trust increased its stake in Trident Texofab Ltd by acquiring 39,425 shares (0.26%) in the open market on August 17, 2026. The promoter group entity now holds 10,18,691 shares, amounting to a 6.79% stake in the company. The disclosure was made to BSE under SEBI takeover regulations, with no encumbrances reported on the shares.

*this image is generated using AI for illustrative purposes only.
The Hardik Desai Family Trust, identified as part of the promoter group of Trident Texofab , acquired an additional stake in the textile manufacturer through the open market. The trust purchased 39,425 equity shares on August 17, 2026, representing a 0.26% increase in its voting power relative to the total share capital.
Following this acquisition, the trust’s total holding stands at 10,18,691 shares, which accounts for 6.79% of the company’s total voting capital. Prior to this transaction, the entity held 9,79,266 shares, constituting a 6.53% stake. The disclosure was filed with BSE Limited on August 20, 2026, in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Shareholding Structure
The acquisition was conducted entirely through the open market mechanism. The disclosure indicates no changes to the company’s total equity share capital, which remains at Rs. 14,99,57,640 (1,49,95,764 equity shares of Rs. 10 each). There were no warrants, convertible securities, or other instruments entitling the acquirer to receive shares carrying voting rights involved in this transaction.
| Metric | Before Acquisition | Change | After Acquisition |
|---|---|---|---|
| Shares held | 9,79,266 | +39,425 | 10,18,691 |
| Stake percentage | 6.53% | +0.26% | 6.79% |
| Encumbered shares | - | - | - |
Regulatory Compliance
The filing was submitted by Hardik Jigishkumar Desai, acting as trustee for the Hardik Desai Family Trust. The document confirms that the acquirer belongs to the promoter category and lists Trident Texofab Limited as the target company. The trust’s address is recorded as Seema Row House, Opp Krushi Farm, Ghod Dod Road, Umra, Surat.
No shares were reported as encumbered with pledge, lien, or non-disposal undertakings either before or after the acquisition. The total diluted share/voting capital of Trident Texofab remains unchanged at Rs. 14,99,57,640 post-transaction.
Historical Stock Returns for Trident Texofab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.99% | +1.47% | -34.31% | -78.33% | -89.86% | -40.30% |
Does this incremental open-market purchase signal the promoter group's confidence in Trident Texofab's upcoming financial performance or strategic initiatives?
How might this consolidation of promoter holding impact market sentiment and liquidity for retail investors in the near term?
Are there indications that the Hardik Desai Family Trust plans to cross the 7.5% or 10% disclosure thresholds, potentially triggering further regulatory filings?


































